GlassScriptPhysician profile
Major Reid
NPI 1366541468
$2,215.81
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $472 · 2021: $972 · 2022: $423.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $334.32 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $198.25 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $181.82 | 2020-2021 | |
| Pfizer INC. | $171.99 | 2019-2021 | |
| Abbvie INC. | $132.53 | 2021 | |
| Gilead Sciences, INC. | $118.69 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.61 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $96.46 | 2019-2021 | |
| Amgen INC. | $86.69 | 2019-2022 | |
| Lilly USA, LLC | $79.32 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.04 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $67.24 | 2022 | |
| Merck Sharp & Dohme LLC | $54.13 | 2019-2022 | |
| Dynavax Technologies Corporation | $50.34 | 2019-2021 | |
| Shire North American Group INC | $48.69 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $44.88 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $44.11 | 2021 | |
| Glaxosmithkline, LLC. | $37.01 | 2020-2021 | |
| Allergan, INC. | $36.53 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $35.05 | 2021-2022 | |
| Amarin Pharma, INC. | $23.60 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $23.56 | 2021 | |
| Viiv Healthcare Company | $18.68 | 2022 | |
| Genentech USA, INC. | $17.55 | 2020 | |
| Lantheus Medical Imaging, INC. | $16.45 | 2022 | |
| Neos Therapeutics, LP | $15.64 | 2022 | |
| Dermira, INC. | $15.33 | 2020 | |
| Daiichi Sankyo INC. | $15.13 | 2019 | |
| Adlon Therapeutics L.P. | $14.91 | 2020 | |
| Kaleo, INC. | $13.47 | 2022 | |
| Ethicon US, LLC | $12.02 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.39 | 2019 | |
| Sanofi Pasteur INC. | $11.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Major Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.